R. Kreienberg
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies 136
- Reproductive Medicine top 0.2%
- Ovarian cancer diagnosis and treatment 44
- Oncology top 0.5%
- Cancer Treatment and Pharmacology 52
- HER2/EGFR in Cancer Research 31
- Obstetrics and Gynecology top 0.5%
- Endometrial and Cervical Cancer Treatments 26
- Family Practice top 1%
-
- Breast Lesions and Carcinomas 36
-
- Clinical practice guidelines implementation 27
-
- Estrogen and related hormone effects 25
- Co-authors
- Achim WöckelThorsten KühnA. RieberMichael UntchIngo B. RunnebaumLukas SchwentnerManfred WischnewskyVolker Möbus
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
R. Kreienberg
403 papers receiving 10.3k citations
Peers
Comparison fields: 5 of 161
- Cancer Research 3.4k
- Reproductive Medicine 1.5k
- Oncology 4.3k
- Obstetrics and Gynecology 845
- Family Practice 198
Countries citing papers authored by R. Kreienberg
This map shows the geographic impact of R. Kreienberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Kreienberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Kreienberg more than expected).
Fields of papers citing papers by R. Kreienberg
This network shows the impact of papers produced by R. Kreienberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Kreienberg. The network helps show where R. Kreienberg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R. Kreienberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 21 | |
| 2 | 2019 | 9 | |
| 3 | 2017 | 9 | |
| 4 | 2017 | 5 | |
| 5 | 2013 | 273 | |
| 6 | 2010 | 126 | |
| 7 | 2010 | 55 | |
| 8 | 2009 | 83 | |
| 9 | 2009 | 1 | |
| 10 | Anthracycline and trastuzumab in breast cancer treatment. | 2004 | 6 |
| 11 | 2004 | 18 | |
| 12 | 2004 | 66 | |
| 13 | 2003 | 76 | |
| 14 | 2003 | 21 | |
| 15 | Long time therapy with topotecan in patients with recurrence of ovarian carcinoma. | 2002 | 15 |
| 16 | 2002 | 19 | |
| 17 | [Therapy of anthracycline-resistant metastatic breast carcinoma]. | 1998 | 1 |
| 18 | [Diabetes screening in pregnant patients with different risk factors. Benefits, therapeutic success, consequences]. | 1996 | 1 |
| 19 | 1994 | 2 | |
| 20 | 1993 | 17 |
About R. Kreienberg
R. Kreienberg is a scholar working on Cancer Research, Oncology and Reproductive Medicine, having authored 434 papers that have together received 10.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (136 papers), Cancer Treatment and Pharmacology (52 papers), Ovarian cancer diagnosis and treatment (44 papers), Breast Lesions and Carcinomas (36 papers), HER2/EGFR in Cancer Research (31 papers), Clinical practice guidelines implementation (27 papers), Endometrial and Cervical Cancer Treatments (26 papers) and Estrogen and related hormone effects (25 papers). The work is most often cited by research in Cancer Research (3.4k citations), Reproductive Medicine (1.5k citations) and Oncology (4.3k citations). R. Kreienberg has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Achim Wöckel, Thorsten Kühn, A. Rieber, Michael Untch, Ingo B. Runnebaum, Lukas Schwentner, Manfred Wischnewsky, Volker Möbus, Georg Sauer and Thomas Beck. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.